University of Münster

Futó vizsgálatok

• Még nem toboroz

  Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR

  2024-517295-37-00· 3. fázis· University Of Cologne· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.

  2025-525030-57-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis

  2026-526184-38-00· 2. fázis· Enveda Therapeutics Inc.· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis

  2026-525673-39-00· 2. fázis· Apollo Therapeutics Limited· Forrás

• Toboroz

  Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

  NCT07680790· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Toboroz

  A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.

  2025-524488-18-00· 2. fázis· Astellas Pharma Global Development Inc.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07690371· 3. fázis· Nektar Therapeutics· Forrás

• Még nem toboroz

  A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis

  2024-515627-10-00· 1/2. fázis· Bonsai Biotherapeutics AB· Forrás

• Toboroz

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

  NCT07225270· 3. fázis· Genmab· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07287150· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants

  2025-521762-99-00· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Toboroz

  A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

  NCT07431177· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  NCT07409272· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  NCT07223203· 3. fázis· Alnylam Pharmaceuticals· Forrás

• Toboroz

  Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

  NCT07441395· 2. fázis· Corvus Pharmaceuticals, Inc.· Forrás

• Toboroz

  Neoadjuvant Darovasertib in Primary Uveal Melanoma

  NCT07015190· 3. fázis· IDEAYA Biosciences· Forrás

• Toboroz

  A Study in Adults with Parkinson's Disease and a Lack of Interest or Motivation to Test How Different Doses of IRL757 Given for Multiple Days are Tolerated in the Body

  2025-523612-37-00· 1. fázis· Integrative Research Laboratories Sweden AB· Forrás

• Fut, nem toboroz

  A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

  NCT07230860· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  NCT07217587· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.

  2024-512503-39-00· 4. fázis· Medizinische Hochschule Hannover· Forrás

• Toboroz

  A Study of LAD603 in Adults With Alopecia Areata

  NCT07311564· 2. fázis· Almirall, S.A.· Forrás

• Toboroz

  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  NCT07221188· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

  NCT07250802· 3. fázis· Takeda· Forrás

• Toboroz

  A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  NCT06979453· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  NCT06807281· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

  NCT07217015· 2. fázis· Kymera Therapeutics, Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

  NCT06804811· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

  NCT05293080· 3. fázis· Universitätsklinikum Hamburg-Eppendorf· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· AbbVie· Forrás

• Toboroz

  Effect of TRI-001 in patients with chronic limb threatening ischemia

  2024-517765-16-00· 1/2. fázis· Ferring Ventures GmbH· Forrás

• Toboroz

  Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

  NCT07197307· 2. fázis· Universität Münster· Forrás

• Toboroz

  Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

  NCT07026474· 3. fázis· Universität des Saarlandes· Forrás

• Toboroz

  Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

  NCT07151378· 3. fázis· University Hospital Tuebingen· Forrás

Showing 50 of 166.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok18 toboroz
• Akut limfoid leukémia (ALL)9 toboroz
• Atópiás dermatitisz (ekcéma)9 toboroz
• Tüdőrák7 toboroz
• Prosztatarák6 toboroz
• Áttétes emlőrák5 toboroz
• Hólyagrák5 toboroz
• Parkinson-kór5 toboroz
• Pikkelysömör5 toboroz
• Szarkóma5 toboroz
• Zsírmáj (MASLD/MASH)5 toboroz
• Akut mieloid leukémia (AML)4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)4 toboroz
• Méhtestrák4 toboroz
• Neuroblasztóma4 toboroz
• Petefészekrák4 toboroz
• Follikuláris limfóma3 toboroz
• Hasnyálmirigyrák3 toboroz
• Időskori makuladegeneráció3 toboroz
• Máj- és epeúti rák3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Stroke (szélütés)3 toboroz
• Vastagbélrák3 toboroz
• Alzheimer-kór2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hodgkin-limfóma2 toboroz
• Melanóma2 toboroz
• Myasthenia gravis2 toboroz
• Peripheral artery disease2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Tripla negatív emlőrák2 toboroz
• Alopecia areata1 toboroz
• Amiloidózis1 toboroz
• Coeliac disease1 toboroz
• Colitis ulcerosa1 toboroz
• Glioblasztóma1 toboroz
• Hidradenitis suppurativa1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Liver cirrhosis1 toboroz
• Lupus (SLE)1 toboroz
• Méhnyakrák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pitvarfibrilláció1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  NCT07630974· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Study Evaluating BFB759 in Atopic Dermatitis

  2025-521624-30-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Lezárult

  GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.

  2025-521107-42-00· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Leállították

  A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

  NCT06987968· 2. fázis· Genfit· Forrás

• Lezárult

  Phase 2, randomized, double-blind, placebo-controlled study of IC0624 as first-line therapy in patients with active mild to moderate Hidradenitis Suppurativa (HS)

  2024-518180-35-00· 2. fázis· Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

  2024-511057-22-00· 3. fázis· Janssen Cilag International· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

  NCT06602219· 2. fázis· DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511360-87-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06603077· 2. fázis· Avalo Therapeutics, Inc.· Forrás

• Lezárult

  A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

  NCT06588738· 3. fázis· Alumis Inc· Forrás

• Fut, nem toboroz

  A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

  NCT06544616· 2. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás

• Lezárult

  A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

  NCT06383403· 3. fázis· Ipsen· Forrás

• Lezárult

  Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

  NCT06430671· 1. fázis· Cellerys AG· Forrás

• Lezárult

  A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered in participants with PD-L1 ≥ 1% TC Stage IIB, IIIA, or select IIIB (T3N2 only) NSCLC following resection and adjuvant platinum-based chemotherapy

  2023-506696-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis

  2023-506655-19-00· 2. fázis· Genentech Inc.· Forrás

• Lezárult

  A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

  NCT06333860· 4. fázis· AbbVie· Forrás

• Lezárult

  EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE

  NCT06079190· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Leállították

  A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

  NCT06220669· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin

  NCT06521190· 2. fázis· Acousia Therapeutics GmbH· Forrás

• Lezárult

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· 3. fázis· Takeda· Forrás

• Leállították

  Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

  NCT06050434· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Lezárult

  A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06046729· 2. fázis· Eli Lilly and Company· Forrás

• Leállították

  Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

  NCT05900050· 2. fázis· Genfit· Forrás

• Lezárult

  A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)

  2022-501538-44-00· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.

  2024-517377-24-00· 1. fázis· Medac Gesellschaft fuer klinische Spezialpraeparate mbH· Forrás

• Fut, nem toboroz

  IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

  NCT05155254· 3. fázis· IO Biotech· Forrás

• Fut, nem toboroz

  A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

  NCT05374512· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

  NCT05201638· 3. fázis· Immunic AG· Forrás

• Fut, nem toboroz

  Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

  NCT05134441· 3. fázis· Immunic AG· Forrás

• Lezárult

  Evaluation of the feasibility of PD L 506 for stereotactic interstitial photodynamic therapy (iPDT) in adult patients with newly diagnosed supratentorial IDH wild-type glioblastoma

  NCT03897491· 2. fázis· Photonamic GmbH & Co. KG· Forrás

• Lezárult

  An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

  NCT04941768· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás

• Lezárult

  Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss

  NCT04929470· Advanced Bionics AG· Forrás

• Lezárult

  Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1)

  NCT04797780· 3. fázis· Syros Pharmaceuticals Inc.· Forrás

• Lezárult

  Study of Orally Administered CA-4948(IRAK4i) as a Monotherapy in patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

  NCT04278768· 1/2. fázis· Curis Inc.· Forrás

• Lezárult

  Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

  NCT04738162· 2. fázis· Universität Münster· Forrás

• Lezárult

  Open Label 2-Arm Study of Venetoclax in Combination with Azacitidine Versus Best Supportive Care after Allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML)

  NCT04161885· 3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Lezárult

  Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)

  NCT04330820· 1/2. fázis· Technische Universität Dresden· Forrás

• Lezárult

  Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

  NCT04318938· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Fut, nem toboroz

  IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

  NCT04086264· 1/2. fázis· AbbVie· Forrás

• Lezárult

  MRD-guided treatment with pembrolizumab and azacitidine in NPM1mut AML patients with an imminent hematological relapse

  NCT03769532· 2. fázis· Technische Universitaet Dresden· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

  NCT03952559· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma

  NCT03341520· 2. fázis· Heidelberg University· Forrás

• Lezárult

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· 3. fázis· Pfizer· Forrás

• Lezárult

  Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

  NCT03075423· 2. fázis· Goethe University· Forrás

• Lezárult

  Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

  NCT02853331· 3. fázis· Merck Sharp & Dohme LLC· Forrás

Showing 50 of 51.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Depresszió76 munka · 1 vizsgálat
• Skizofrénia46 munka · 0 vizsgálat
• Bipoláris zavar38 munka · 0 vizsgálat
• Sclerosis multiplex (SM)34 munka · 10 vizsgálat
• Liver cirrhosis7 munka · 3 vizsgálat
• Vitiligo6 munka · 4 vizsgálat